Monday, 22 June 2020

Superdisintegrants Systems Market 2020 Global Trend, Segmentation And Opportunities - Forecast To 2023

Market Scenario:
The Global Superdisintegrants Market is anticipted to grow at an optimistic CAGR of 7.9% during the forecast period from 2018 to 2023. Disintegrants are substances which are included in drug formula to allow proper disintegration of the capsule or tablet into easily dissolvable particles. This plays a vital function in the fast absorption of medicine which increases its efficacy. Superdisintegrants are slightly modified disintegrants which offer higher efficiency than their traditional counterparts. Observed to have valued at USD 371 Mn in 2017, the global superdisintegrants market size is poised to appreciate to reach an estimated value of USD 576.2 Mn by the end of 2023.
The pharmaceutical industry is growing at breakneck speed, becoming a significant part of the healthcare sector. This is primarily due to rising populations of both geriatric patients and pediatric patients. Superdisintegrants are helpful for treatment of patients from this demographic as these tablets are easier to swallow. The growth of these demographics is expected to drive market growth. Moreover, generic drugs are in high demand as patents have begun to run out on several popular drug brands, thus opening up the pharmaceutical industry for increased entry of competition and a rise in the manufacturing of generic drugs, thus driving superdisintegrants market demand 
Emerging markets represent significant opportunity as the healthcare sectors in these regions are growing at a swift pace. Moreover, large patient pools are in these countries are expected to increase demand for fast-acting medication. Market players are likely to establish themselves in the region in an effort to leverage the opportunities available in emerging economies.
Players Covered
Prominent market participants that have been profiled in the report include Asahi Kasei Corporation, DFE Pharma, JRS Pharma, Corel Pharma Chem, Ashland Global Holdings Inc., BASF SE, Roquette Freres, DowDuPont Inc., Merck KGaA, and Avantor Performance Materials, LLC
Market Segmentation
MRFR's analysis of the various segments in the market has been performed on the basis of type, formulation, therapeutic area, and region. Types of superdisintegrants have been segmented into synthetic superdisintegrants, natural disintegrants, and others. Among these, the synthetic superdisintegrants segment has been widely used, making it the most significant market segment. However, the natural superdisintegrants segment is growing at a truly rapid pace due to the growing demand for natural ingredients.
Formulations which include superdisintegrants have been segmented into tablets and capsules. Tablets govern a majority share of the total market, while the capsules segment is expected to grow at the highest CAGR during the review period.
Therapeutic areas where superdisintegrants are used have been segmented into gastrointestinal diseases, neurological diseases, oncology, infectious diseases, inflammatory diseases, hematological diseases, and cardiovascular diseases. Among these segments, the gastrointestinal diseases segment is at the forefront of market growth due to the demand for fast acting medicine for these types of diseases. Meanwhile, the oncology segment is growing rapidly and is expected to display the highest CAGR over the forecast period.
Regional Analysis
Led by the U.S, the Americas have captured the largest share of the global superdisintegrants market. The presence of a developed healthcare sector as well as several important market players that have and continue to influence growth and contribute to the sizeable share that this regional market possesses. The region also has a high demand for drugs for many chronic diseases where superdisintegrants are required due to the prevalence of such diseases.
The Asia Pacific superdisintegrants market is likely to grow at the highest pace due to the concentration of rapidly emerging markets in the region. China, Japan, India, and several other country-level markets have a high demand for drugs for chronic diseases. The APAC regional market has several avenues for growth that are expected to open up in the coming years. The regions rapidly growing healthcare sector and the presence of a number of contract manufacturing organizations for pharmaceuticals is likely to have a positive impact on the market.
Posted by at No comments:

Global Antihypertensive Drugs Market 2020 – Investment Strategy, Outlook And Key Development Till 2023

According to a recent study report published by the Market Research Future, The global market of  Anti-Hypertensive Drugs was valued at $32.2 billion in 2015, and is projected to reach $ USD 41.2 billion by 2023. Thus the global anti-hypertensive drugs market is anticipated to observe a sluggish growth; at a CAGR of 2.73% during 2016 to 2022.
Anti-Hypertensive Drugs are used to treat hypertension (high blood pressure). Hypertension is a state of chronic elevated arterial blood pressure at or greater than 140/90 mm Hg for adults. Hypertension is one of the most powerful risk factors for cardiovascular morbidity and mortality. There exact cause of hypertension is unknown but is said that unhealthy, heady lifestyle and ageing mirror such disorders as “Hypertension”.
The major market driving factors for secondary hypertension are greater detection and early diagnosis. Rise in the prevalence diseases such as kidney problems, thyroid problems, adrenal gland tumours, heart ailments, chronic alcohol use etc. in which anti-hypertensive drugs are used; are some of the other factors driving the growth of the Anti-Hypertensive Drugs market. The constraints however are overwhelming and include patent expiries such as Actelion's Tracleer (2015), and United Therapeutic's Remodulin (2014). Other blockbuster’s such as Novartis's Diovan and Exforge, Sanofi Aventis's Avapro (2012) etc are also off-patent.
Many antihypertensive drugs have their primary action on systemic vascular resistance. Some of these drugs produce vasodilation by interfering with sympathetic adrenergic vascular tone (sympatholytics) or by blocking the formation of angiotensin II or its vascular receptors. Other drugs are direct arterial dilators, and some are mixed arterial and venous dilators. Although less commonly used because of a high incidence of side effects, there are drugs that act on regions in the brain that control sympathetic autonomic outflow. By reducing sympathetic efferent activity, centrally acting drugs decrease arterial pressure by decreasing systemic vascular resistance and cardiac output.
Some antihypertensive drugs, most notably beta-blockers, depress heart rate and contractility (this decreases stroke volume) by blocking the influence of sympathetic nerves on the heart. Calcium-channel blockers, especially those that are more cardioselective, also reduce cardiac output by decreasing heart rate and contractility. Some calcium-channel blockers (most notably the dihydropyridines) are more selective for the systemic vasculature and therefore reduce systemic vascular resistance.
Segmentation
The Anti-Hypertensive Market can be segmented in to 4 key dynamics for the convenience of the report and enhanced understanding;
Segmentation By Pharmacological Class               : Comprises Diuretics, ACE Inhibitors, Calcium Channel Blockers, Adrenergic Blocker and other.
Segmentation By Hypertension Type                      : Comprises Systemic and Pulmonary Hypertension Drugs and other.
Segmentation By Disease Source                              : Comprises Primary and Secondary.
Segmentation By Regions                                            : Comprises Geographical regions - North America, Europe, APAC, including Anti-Hypertensive Drugs Market in India and Rest of the World.
Regional Analysis
The antihypertensive drugs market covers growth drivers in the following regions, namely Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). The Americas accounted for a large market share owing to high prevalence of hypertension linked to cardiovascular and renal disorders. Drives by government and non-government organizations for creating awareness of the medical condition are likely to bolster the revenue of the antihypertensive drugs market in Americas.
The Europe region was the second-largest due to rise of cardiovascular diseases, unhealthy diets, and increase noticed in obesity levels of patients. According to the European Heart Network in 2017, heart diseases accounted for 3.9 million deaths. Germany, France, and the U.K. are expected to be the prime contributors to the antihypertensive drugs market in Europe.
The APAC region is projected to exhibit a robust pace owing to increased healthcare budget and rise in disposable income levels of patients. The setup of research and development centers to fast-track the commoditization of drugs for treating hypertension is likely to boost the APAC antihypertensive drugs market.
Key Players
Novartis AG, Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer Ingelheim, Sanofi S.A., Astra Zeneca plc, Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceuticals Company Limited, Pfizer Inc. are some of the prominent players at the forefront of competition in the Global Market of Anti-Hypertensive Drugs and are profiled in MRFR Analysis.
Posted by at No comments:

Global Clear Aligners Market 2020 Size, Trends, Industry Analysis, Leading Players & Future Forecast By 2025

Clear Aligners market is anticipated to expand at a CAGR of 20.80% in the duration of the forecast period. Market Research Future presents Clear Aligners Industry future scope with Information by Product Type (Hard, Medium and Soft), Age (Adult and Teenager), Distribution Channel (Direct Sales and Laboratories) and Regional Analysis, Forecast till 2025
The increasing level of acceptance and demand for clear aligners is amplifying the expansion of the market steadily. The benefits of clear aligners are multiplying the number of individuals who are opting for it. This is primarily due to the improving number of individuals electing for cosmetic dental procedures since the past few years. The clear aligners market is expected to progress at a 20.80% CAGR while earning revenues worth USD 3982.30 Million in the duration of the forecast period. The evolution in terms of technology such as 3D printing, dental CAD software, and thermoforming machines is projected to transform the market favorably in the coming years.
Rapid technological advancement is aiding the evolution of dentistry with the development of advanced dental devices. Rise in prevalence of dental diseases and increase in geriatric population all over the world are inducing high demand for advanced dental devices which is leading to the significant growth of the global clear aligners market. High healthcare expenditure in developed and developing regions and increasing popularity of aesthetic dentistry among young population have created multiple opportunities for the expansion of the global clear aligners market. However, the treatment time required for clear aligners is comparatively higher than other procedures. Hence, the high treatment time, availability of cheaper products and lack of awareness among the population of underdeveloped areas are posing as a threat to the growth of the global clear aligners market.
Competitive Dashboard:
Globally, a large number of companies are working in the development and production of clear aligners. These major companies have adopted extensive research, in order to offer better and cost-effective products. The American and European regions are a hub for major companies, generating maximum market share which has turned these regions into a well-established market. These companies have expanded their operating units in various other regions as well. Moreover, there are various other small and medium scale players that generate revenue from the local market.
Some key players operating in this market are
  • Align Technology, Inc.,
  • Institut Straumann AG,
  • Danaher Corporation,
  • Dentsply Sirona,
  • Clarus,
  • 3M, among others.
Segmentation:
The global clear aligners market has been segmented into product type, age, distribution channel, and region.
Based on product type, the global market has been segmented into hard, medium, and soft.
Based on age, the global market has been divided into teenager and adult. The teenager segment is likely to hold the maximum share in the global market with a value of 1427.98 million in 2018.
Based on distribution channel, the global market has been divided into direct sales and distributor.
Detailed Regional Analysis:
The global clear aligners market, based on region, is segmented into– the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is expected to command the largest market share due to aesthetic dentistry and other vast specialized services present in countries of North America. Additionally, the rising health expenditure per person and increasing demand for advanced technologies are driving the growth of the clear aligners market in these countries. Additionally, the presence of a large number of noticeable players in this region is the major driving factor of the market in the Americas.
Europe accounts for the second-largest market, majorly due to the soaring demand for dental procedures. Additionally, the increasing incidences of oral problems, vast application of technologically advanced techniques, and the growing importance of treatment, planning, and diagnosis in implant dentistry in European countries are driving the clear aligners market in Europe.
Asia-Pacific with lots of opportunities and continuously growing economies is expected to be the fastest-growing region. Furthermore, recent developments in healthcare and improving economies and disposable income per individual are fueling market growth.
The Middle East & Africa is expected to grow significantly during the forecast period due to the increasing cases of dental abnormalities and the demand for better teeth-related treatments in the region.
Browse Clear Aligners Market by Product Type, Age, Distribution Channel and Region @ https://www.marketresearchfuture.com/reports/clear-aligners-market-6974
Posted by at No comments:

Liquid Biopsy Market 2020 Global Growth Insights, Trends, Size, Share And Forecast To 2022

Liquid Biopsy Market Research Report: Information by Biomarker Types (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (CTDNA), Extracellular Vesicles (EVS) and other Biomarker (Circulating RNA and Proteins)), Application (Cancer Therapeutic Application, Reproductive Health and Other Therapeutic Application), Sample (Blood Sample, Urine Sample and other), End User (Hospitals and Laboratories, Academic and Research Centers and other End Users) and Region (North America, Europe, Asia-Pacific and Middle East & Africa) - Global Forecast to 2022
Market Insights:
Liquid biopsy overcomes these problems of tissue biopsy by using biomarkers present in samples such as blood, urine etc. and thus is a comparatively non-invasive technique. Liquid biopsy also provides greater information about the sample which is real time. The real time data can be used for monitoring and thereby determining the treatment for diseases such as cancer. The greater sensitivity of tissue biopsy coupled with the development of sophisticated detectors with extremely low detection rates have enabled the early detection of diseases which is the holy grail of cancer.
Biopsy involves extracting a sample of tissue and testing it for the presence of diseases especially cancer. Traditional tissue biopsy is a painful technique and also has a high rate of false results. Moreover the technique is costly, time consuming and not applicable for extracting samples such as those close to vital organs such as heart.
Segmentation:
Global Liquid Biopsy market has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker. On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application. On the basis of sample; market is segmented into blood, urine and others. On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centres and others.
Major Players

  • Guardant Health, Inc.,
  • Trovagene, Inc.,
  • RainDance Technologies, Inc.,
  • Agena Bioscience Inc. Inc.,
  • Admera Health,
  • Biocept, Inc.,
  • Circulogene Theranostics,
  • Inivata Ltd.,
  • SAGA Diagnostics AB,
  • Exosome Diagnostics and others.

Drivers
The market drivers for the liquid biopsy market growth are rising rates of cancer, growing investment in research and development, collaborations between companies and public organizations, rise in geriatric population, rising expenditure on health etc. The factors which are inhibiting the growth of the market includes the prohibitive costs associated with liquid biopsy and the differential awareness and availability between developing and the developed world. However, not all cancer patients benefit from early detection as some cancer types such as brain cancer and prostate cancer may lie dormant for many years. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.
Also the technique is not applicable to all types of cancer as some cancers such as brain cancer and prostate cancer may lie dormant for many years, and thus are either undetectable or detected very late which robs liquid biopsy of its advantages. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.

Regional Analysis:
Depending on geographic region, Liquid biopsy market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally developed countries led by North America is the largest market for Liquid biopsy. Europe is the second-largest market for liquid biopsy. The developing regions market such as Asia pacific region and Middle East & Africa however is rising much faster.
Key findings
  • Circulating tumor cells (CTCs) segment dominates both in terms of market share as well as revenues, contributing approx. 55.48% of the revenue share of the liquid biopsy market.
  • On the basis of the therapeutic application, the segment for Cancer will reflect the highest growth potential, with over 82.83% of the market share by revenues. However, the urine sample segment is anticipated to witness noticeable growth.
  • The market for liquid biopsy is dominated by North America and Europe and this trend will continue. Asia-Pacific market is the fastest growing market and is expected to grow at a CAGR of 29.7% during forecasted period
Posted by at No comments:

2020 Latest Study Explores The CBD Market Witness Highest Growth In Near Future By 2026

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “CBD Market Research Report - Global Forecast till 2026” Gives industry size, top players and worldwide demand
CBD (Cannabidiol) Market: Information by Form (Solid and Liquid), Route of Administration (Tincture, Capsules, Inhalation (Smoke or Vapor) , Aerosol Spray), Product (Food Grade and Therapeutic Grade), Application (Neurogenerative Disorder, Fibromyalgia, Diabetes , Protein Bars , Energy Drinks), End User (Food & Beverage, Healthcare), Source (Organic Inorganic) and Region (North America, Europe, Asia Pacific, ROW) - Global Forecast till 2026
CBD Market Overview
The Global CBD Market Growth is expected to register a CAGR of 125.58% to reach USD 22,07,162.54 Million by 2026.
Cannabidiol (CBD) is a safe, non-addictive substance found in the cannabis plant. CBD is the second-most abundant cannabinoid found in cannabis after tetrahydrocannabinol (THC). CBD has significant therapeutic benefits such as anti-inflammatory, analgesic, anti-anxiety, and seizure-suppressant properties. According to a survey by the National Center for Biotechnology Information (NCBI) conducted between 2017 and 2018, about 62% of the population used CBD to treat a medical condition.
The growing research & development and financial support by various private and government organizations for cannabinoid research, rising occurrence of chronic diseases and related complications, and legalization of CBD in various regions are expected to have a positive impact on the global cannabidiol (CBD) market. However, adverse effects associated with cannabis and stringent government policies are anticipated to restrain the growth of the global CBD market size.
CBD Market Dynamics
Growing research and development activities and financial support by various private and government organizations for cannabinoid research- There are many private and government organizations supporting the research and development for cannabinoids for medical purposes. Cannabis has numerous medicinal properties by which it can cure various diseases. According to the National Institute of Drug Abuse, May 2018 publication, in 2017, the National Institute of Health (NIH) supported 330 projects and spent USD 140 million on cannabinoid research and development. During this investment, USD 36 million was spent on 70 projects to examine the therapeutic properties of cannabis, and USD 15 million was spent on 26 projects centered on cannabinoid (CBD). Even in 2016, NIH spent USD 21 million studying therapeutic properties of cannabinoids. Singapore, known for the world's most stringent drug laws, is also funding research projects on medical treatments containing synthetically derived compounds of the cannabis plant. In 2017, the government-run National Research Foundation launched a program to research the therapeutic potential of cannabinoids.
CBD Market Regional Analysis
The Americas dominate the global CBD market, owing to the increasing consumption of cannabis-based products. According to the World Health Organization (WHO), the consumption of marijuana has an annual prevalence rate of nearly 2.5% of the global population, i.e., approximately 147 million individuals. It is also reported that approximately 22.2 million Americans of 12 years of age and older use cannabis and related products for various reasons.
Europe holds the second largest market share due to the rising awareness about clinical applications of cannabis. CBD is legal and can be openly marketed in certain European countries, for instance, the Ministry of Agriculture, Food and Forestry, and the Bulgarian Food Safety Agency issued the ‘free certificate of sale’ for the CBD products. Thus, such approvals and consideration by the regulatory agencies in Europe are driving the CBD market growth in the region. In spite of the approvals and considerations, there are positive restrictions associated with the use of the products. For instance, in 2013, medical cannabis was legalized in the Czech Republic, but it was limited to 180 grams of dry matter per month. In Europe, marijuana and cannabis laws differ from country to country. Previously, Germany was importing medical cannabis from other countries, but in 2017, Germany passed a law to expand access to medical cannabis and to allow domestic production. Increasing participation of various companies such as Medical Marijuana Inc., as a scope of development, announced the formation of Canipa Holdings in Romania, European Union. The effect of such initiatives by the companies is facilitating the growth of the CBD market in the European region.
The Asia-Pacific region is classified into CBD Market China, CBD Market India, CBD Market Japan, and Rest of Asia-Pacific. It holds the third largest position in the CBD market. Recently, China has legalized the cultivation of CBD (Hemp) and extraction for the derived product. The products are exported and not sold in China. Yunnan provincial government and Public Security Bureau approved the first industrial hemp plant extraction factory in China. It is the largest country in terms of area, population, businesses, and others. The entry of Chinese companies in the CBD market has created a great potential for expansion and growth. In Asia-Pacific, cannabis-based products are completely unacceptable. But due to the increasing cases of epilepsy, cannabis-based products are prescribed by some physicians. For instance, a recent Australian nationwide survey of 976 people with epilepsy indicated that 13% of the parents were using illicit cannabis extracts to manage their child’s seizures. Australia mainly focuses on the medical use of cannabis products. Australian regulatory agencies are operating on providing a guideline for the use of the CBD products. This is expected to help in the growth of the CBD market in Australia.
The Middle East and Africa is expected to witness a restricted growth due to stringent government policies, adverse effects associated with cannabis, and the illegal use of marijuana. In the Middle East, few of the Arab countries are imposing trick laws over the use and handling of cannabis-related products. Thus, the CBD market in these regions has limited scope for growth during the forecast period.
Segmentation
On the basis of form, the global cannabidiol market is segmented into solid and liquid.
In the solid form of CBD, the report covers CBD crystals, CBD wax, capsule/softgel, hash, and others. The liquid form of CBD includes CBD oil, tincture, cream, e-liquid, and others.
CBD crystals are a pure form of CBD isolates. CBD crystals are produced by heating CBD rich extract and then continuous cooling and separating it. CBD crystals are generally used to manufacture CBD infused edibles and creams. CBD wax is solidified or crystalized full spectrum form of CBD. CBD wax is a highly concentrated form of CBD and especially used for pain relief. CBD capsules are similar in comparison to capsules as they are surrounded by an outer shell, usually gelatin. CBD soft gelatin capsule is a translucent golden shade standard capsule that is filled with hemp oil and sometimes olive oil as filler.
CBD oil is one of the most popular and widely available forms of CBD. It is specifically used for medical purposes as it provides fast and effective results. There are a wide variety of flavors of full spectrum CBD oils available in the market. CBD tinctures are made from high strains of hemp, with 60-70% of alcohol. CBD tinctures are primarily used to relieve anxiety and ease the pain. CBD infused e-liquid are used as a fluid in electronic cigarettes and vaporizers.
CBD Market Key Players
The prominent players in the global CBD market are Aphria Inc., Folium Biosciences, Freedom Leaf, Inc, Green Roads of Florida, LLC, CBD Health Solutions, LLC, ENDOCA, Isodiol International Inc, CV Sciences, Inc, Medical Marijuana, Inc., Canopy Growth Corporation, Elixinol Global Limited.
The players operating in the global CBD market are focusing on product launches, along with expanding their global footprints by entering untapped markets.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/cbd-market-8090 
Posted by at No comments:

Healthcare Personal Protection Equipment Market Overview With Detailed Analysis, Competitive Landscape, Forecast To 2025

Market Forecast

Global Healthcare Personal Protection Equipment Market is expected to cross USD 10.116 Billion by 2027 at a CAGR of 9.17%.  
Market Synopsis
Personal Protective Equipment (PPEs) are protective gear designed to safeguard the health of workers by minimizing the exposure to a biological agent. It is one of the necessary tools in preventing transmission of infectious diseases not only in treatment centers but also in various activities, e.g. cleaning, waste management and safe burials, and community care related to the outbreak. Components of PPE are goggles, face-shield, mask, gloves, coverall/gowns (with or without aprons), head cover, shoe cover, and others.
Healthcare Personal Protection Equipment Market Influencer
PPE helps healthcare workers to fight against novel coronavirus (COVID-19). The World Health Organization (WHO) has recommended the governments across the world to increase the production of masks, gloves, respirators, and coveralls/gowns. It also recommended that PPE manufacturers must increase their production by 40% and prioritizing their orders to the countries with a high demand-supply gap.
Market Drivers
  • As of the 3rd week of April, coronavirus (COVID-19) pandemic crossed 2 million cases globally. The increasing demand for hand protection, respiratory protection, and protective clothing in the healthcare industry to ensure the people’s safety during the ongoing COVID-19 pandemic is expected to boost the demand for Personal Protective Equipment (PPE).
  • Rapid technological advancements in the field of surgery such as High-Reliability Organizing (HRO), technical advancements, and standardizing procedures are expected to have a positive impact on the hospital sector, thereby impacting the demand for personal protective equipment positively.
  • Increasing government initiatives to facilitate the import of personal protective equipment is expected to drive the market growth. For instance, in March 2020, in response to the COVID-19 outbreak, the Food and Drug Administration (FDA) initiated numerous steps to improve US stocks of personal protective equipment. The measures include adjustments in import screening, flexibility to manufacturers, and creation of special mailbox service, among other provisions.
  • The emergence of local PPE manufacturers, increasing end user demand, and the rising production of cost-effective and integrated PPE is expected to boost the market growth. For instance, in India, the Union Textiles Ministry and the Health Ministry has said the government is augmenting the supplies of personal protective equipment (PPEs), including body coveralls, N-95 masks and 2-ply/3-ply surgical masks required for healthcare professionals dealing with COVID-19 cases. Furthermore, more than 130 Australian companies have responded to an urgent call to dramatically boost the manufacturing of face masks, gowns, and gloves to deal with the COVID-19 crisis.
Market Restraints
  • The current global stockpile of PPE is inadequate to handle the existing and expected cases in different parts of the world, particularly for medical masks and respirators. The supply of gowns and goggles is also expected to be insufficient as the disease is spread. Surging global demand is not only driven by the increasing number of COVID-19 cases but also by misinformation, hoarding, and panic buying. The lockdown in a significant portion of the world is hampering the manufacturing of PPE.
  • The high cost of raw materials (specialized clothing and other related products) is hindering the demand for PPEs in economically weak countries.

Healthcare Personal Protection Equipment Market Segmentation

By Product
  • Protective Clothing: The protective clothing is further segmented into coveralls, gowns, and others. Coverall/gowns are designed to protect the torso of healthcare providers from exposure to the virus.
  • Respiratory Protection: Respiratory protection is bifurcated into surgical masks, respirator masks, and others. The healthcare professionals are recommended to use surgical N95 respirators or medical respirators to protect them from the direct exposure to the COVID-19 virus.
  • Head, Eye, and Face Protection: The largest segment. To prevent exposure of the eye and face from the virus, goggles or a face shield should be considered. High risk of COVID-19 and other infections through nose, eyes, and ears is among the primary reason driving the growth for this segment. The goggles must fit the contours of the user’s face and are compatible with the respirator. The use of face shields/ goggles is an integral part of standard and contact precautions for the people most at risk of COVID-19 infection.
  • Protective Footwear: The use of protective footwear such as washable and disposable footwear is essential to avoid self-contamination.
  • Hand protection: Hand protection is further sub-segmented into general-purpose, chemical handling, sterile gloves, and surgical. The rising awareness about hygiene and prevention from the transmission of pathogens in healthcare facilities is increasing the demand for medical gloves.
  • Others
By End Use
  • Hospitals & Clinics: The largest segment and expected to grow at the highest CAGR during the forecast period. The rising awareness regarding the hand protection during a viral outbreak is increasing the demand for PPEs in hospitals.
  • Ambulatory Surgical Centers: The increasing number of patients visiting surgical centers is facilitating the demand for PPEs in ambulatory surgical centers.
  • Academic and Research Institutes: PPEs are very effective in minimizing occupational injuries, accidents, and other hazards which otherwise result in substantial manpower and financial losses. The use of basic PPE is a must in research institutes as they protect from skin contact and contamination.
  • Diagnostic Laboratories: The use of protective equipment is necessary for diagnostic laboratories to protect healthcare workers from specific hazards and hazardous materials.
  • Others
By Region
  • Americas: The largest regional market. The increasing government initiatives and rising concerns in terms of health and safety of healthcare professionals is boosting the demand for the same. Moreover, the rising prevalence of COVID-19 infection is majorly contributing to the growth of this region.
  • Europe: The healthcare market in Northern European economies, such as Germany, U.K., and Sweden, is expected to exhibit an increase in healthcare expenditure, thereby leading to the growth in production as well as the consumption of medical devices and products.
  • Asia-Pacific: The fastest-growing regional market. Emerging market players in the region, technological advancements, rising focus of government towards healthcare facilities, and high target population in the region are among the key factors driving the market growth in the region.   
  • Middle East & Africa: The high penetration of personal protective equipment in developed healthcare industries of UAE, South Africa is expected to drive the growth of the market in this region.
Posted by at No comments:

Particle Counter Market 2020 Global Market Trends, Share, Size, Growth, Opportunity And Forecast To 2025

Market Forecast

Global Particle Counter Market size is expected to cross USD 168.2 Million by 2025 at a CAGR of 7.1% during the forecast period of 2019 to 2025.
Market Synopsis
A particle counter is a tool for monitoring indoor air quality to understand the concentration of particles in the air in cleanrooms and workplaces. This device would not identify specifically what kinds of dust particulates are present in the air, but it will identify how many airborne particles of a certain size are present in the environment.
The growing pharmaceutical sector along with stringent regulatory policies are driving the particle counter market growth. Additionally, increasing numbers of growth strategies adopted by major players are further driving the market growth globally. For instance, in June 2019, TSI launched the AeroTrak+ Remote Airborne Particle Counters for monitoring manufacturing cleanrooms.
Market Influencer
Rising production by the pharmaceutical industry and stringent regulations are likely to impact the growth of the particle counter industry positively.
Market Drivers
  • The growing pharmaceutical industry will support the growth of the particle counter market during the forecast period.
  • Rising research & development in the pharmaceutical and biotechnology industry to cater to rising needs for treatments of various chronic diseases is driving the growth of the particle counter market. For instance, according to a recent survey, the pharmaceutical and biotechnology industry in the US spent a total of USD 102 billion on research & development in 2015. Additionally, according to the National Institute for Health Research, the Association of the British Pharmaceutical Industry (ABPI) invested over USD 4.46 billion just in the UK on R&D, looking for breakthroughs for conditions such as cancer, dementia, and rare genetic diseases.
  • Stringent government regulations regarding the quality of air in the pharmaceutical and medical device industry.
  • Rising product launches and product advancements by major market players.
Market Restraints
  • The high cost of particle counters and technical limitations of particle counters is hampering the growth of the global particle counter market.
Particle Counter Market Segmentation
By Product Type
  • Airborne Particle Counters: Airborne particle counters are widely used to monitor signs of cleanroom air contamination, and, in most cases, the particle count data is used to make critical process decisions regarding cleanroom certifications. These airborne particle counters, work on a light scattering principle. They utilize a very bright light source to illuminate the particles.
  • Liquid Particle Counters: Liquid particle counting is used to measure the size and distribution of particles in a liquid or on solid samples. This particle counter works by irradiating a liquid sample with a laser diode and detecting the scattered light. The properties of the scattered light are related to the particle size. The particle size is then measured, and the number of particles present in each size range is determined. Aviation & space exploration, heavy machinery, and automobile manufacturing are the fields where particle control in hydraulic systems plays an important role.
By Technology
  • Online Particle Counters: Online/Inline measuring systems are designed to mount directly to stationary systems for continuous or periodic monitoring or can be used as mobile monitoring solutions in hydraulic and lubricating systems.
  • Offline Particle Counters: Offline particle counters use mineral as the operating fluid, and their portable size makes them most suitable for on-site applications. These particle counters are widely used for automatically measuring & displaying particulate contamination, moisture & temperature levels in various hydraulic fluids.
By Modularity
  • Portable Particle Counters: The portable particle counter holds the majority share in the modularity segment attributing to the high adoption rate of these systems across the globe. Portable particle counters are easy to handle and are designed to save time and money. Demand for portable particle counters is rapidly growing in aerospace, automotive, pharmaceutical, oil & gas, and food & beverage industries.
  • Remote Particle Counters: Remote Particle counters are perfect for monitoring large cleanrooms or critical environments. Their small size, flexible power options, and wireless capabilities make them a preferred option for large clean rooms.
  • Handheld Particle Counters: These particle counters being lightweight and easy to carry, well-suited for cost-effective spot-checking. They are ideal for checking sources of contamination and perform indoor air quality (IAQ) investigations for consistently meeting the air quality parameters.
By End-User
  • Medical Device Industry: In 2018, the medical device industry held the largest share in the market due to increased R&D expenditure and the establishment of new manufacturing facilities by global pharmaceutical giants in newer geographies. Additionally, increasing infections arising due to contaminated devices and the implementation of stringent regulations to maintain air quality is driving the market growth.
  • Pharmaceutical Industry: Pharmaceutical industry accounted for the second-largest market share due to the growing volume of compounds to be detected for the presence of impurities in pharmaceutical samples and stringent safety regulations. Effective sterilization processes are vital within the pharmaceutical industries, and the safety of process units and final products depends on the highest quality of hygienic practice, as well as strict controls and regulatory compliance. Air quality rules and regulations need to be complied to ensure that the product remains sterile. This leads to a rise in the particle counter market as pharmaceutical firms are emphasizing on the use of particle counter methods to ensure air quality.
  • Research Laboratories: Particle countering is a key factor of air quality monitoring in laboratories where products or processes are sensitive to environmental contamination.
  • Others: Others include hospitals, specialty centers, diagnostic centers.
By Region
  • Americas: The Americas held the largest regional market share in 2018. This is owing to the high adoption rate of particle counters and stringent regulations by the FDA. Additionally, product launches and product advancements by major market players are driving the growth in the Americas region.
For instance, in February 2018, Particle Plus launched Particles Plus 2000 series in four size channels—0.3, 0.5, 1.0, and 5.0 µm.
  • Europe: The need for particle counter is high in this region due to growth in the pharmaceutical and medical device industry. Additionally, increasing support from governments, the presence of a huge geriatric population, and rising healthcare spending are driving the market growth.
  • Asia-Pacific: The Asia-Pacific region accounted for the third-largest market share due to presence of a large number of research organizations, low manufacturing cost and labor cost, developing healthcare infrastructure, and increased investments by the American and European market giants in Asian countries such as China and India
  • Middle East & Africa: It is estimated to account for the least share of the global particle counter market due to the limited development of healthcare facilities.
Posted by at No comments:
Subscribe to: Posts (Atom)